ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype

Nature Communications

Volumn 6, Issue , 2015, Pages

  Junankar, Simon ^a,b   Baker, Laura A ^a,b   Roden, Daniel L ^a,b   Nair, Radhika ^a,b   Elsworth, Ben ^a,b   Gallego Ortega, David ^a,b   Lacaze, Paul ^c   Cazet, Aurélie ^a,b   Nikolic, Iva ^a,b   Teo, Wee Siang ^a   Yang, Jessica ^a   McFarland, Andrea ^a   Harvey, Kate ^a   Naylor, Matthew J ^a,b,d   Lakhani, Sunil R ^e,f,g,h   Simpson, Peter T ^e,f,h   Raghavendra, Ashwini ^e,h   Saunus, Jodi ^e,h   Madore, Jason ^e,h   Kaplan, Warren ^a   Ormandy, Christopher ^a,b   Millar, Ewan K A ^a,i,j,k   O'Toole, Sandra ^a,l,m   Yun, Kyuson ⁿ   Swarbrick, Alexander ^a,b   more..

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT'S CLINIC   (Australia)

^c Millennium Science Pty Ltd   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^h QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

ⁱ ST GEORGE HOSPITAL   (Australia)

^j UNIVERSITY OF NEW SOUTH WALES   (Australia)

^k UNIVERSITY OF WESTERN SYDNEY   (Australia)

^l ST VINCENT S HOSPITAL   (Australia)

^m UNIVERSITY OF SYDNEY   (Australia)

ⁿ JACKSON LABORATORY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION 4; INHIBITOR OF DIFFERENTIATION PROTEIN; UNCLASSIFIED DRUG; ID4 PROTEIN, HUMAN; IDB4 PROTEIN, MOUSE; MESSENGER RNA;

CANCER; ETIOLOGY; GENETIC DIFFERENTIATION; GERM CELL; HETEROGENEITY; PHENOTYPE; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL LIKE BREAST CANCER; BREAST CARCINOMA; CANCER PROGNOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAMMARY STEM CELL; MORPHOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; STEM CELL; TRANSCRIPTOMICS; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CYTOLOGY; GENE TARGETING; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UDDER;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE KNOCK-IN TECHNIQUES; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; MAMMARY GLANDS, ANIMAL; MICE; NEOPLASM TRANSPLANTATION; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS;

EID: 84925763569     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7548     Document Type: Article

References (66)

1. Watson, C. J. & Khaled, W. T. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 135, 995-1003 (2008).
2. Bai, L. & Rohrschneider, L. R. s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue. Genes Dev. 24, 1882-1892 (2010).
3. Williams, J. M. & Daniel, C. W. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev. Biol. 97, 274-290 (1983).
4. Li, N. et al. Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells. Stem Cells 26, 1253-1264 (2008).
5. Bouras, T. et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 3, 429-441 (2008).
6. Asselin-Labat, M. L. et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9, 201-209 (2007).
7. Kouros-Mehr, H., Slorach, E. M., Sternlicht, M. D. & Werb, Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127, 1041-1055 (2006).
8. Liu, S. et al. BRCA1 regulates human mammary stem/progenitor cell fate. Proc. Natl Acad. Sci. USA 105, 1680-1685 (2008).
9. Oakes, S. R. et al. The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev. 22, 581-586 (2008).
10. Carr, J. R. et al. FoxM1 regulates mammary luminal cell fate. Cell Rep. 1, 715-729 (2012).
11. Lindvall, C. et al. The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. J. Biol. Chem. 281, 35081-35087 (2006).
12. Zeng, Y. A. & Nusse, R. Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell 6, 568-577 (2010).
13. Stingl, J. et al. Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-997 (2006).
14. Shackleton, M. et al. Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88 (2006).
15. Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015-1028 (2012).
16. Lim, E. et al. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 12, R21 (2010).
17. Nam, H.-S. & Benezra, R. High levels of id1 expression define B1 type adult neural stem cells. Cell Stem Cell 5, 515-526 (2009).
18. Jankovic, V. et al. Id1 restrains myeloid commitment, maintaining the selfrenewal capacity of hematopoietic stem cells. Proc. Natl Acad. Sci. USA 104, 1260-1265 (2007).
19. Perry, S. S. et al. Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance. Blood 110, 2351-2360 (2007).
20. Romero-Lanman, E. E., Pavlovic, S., Amlani, B., Chin, Y. & Benezra, R. Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression. Stem. Cells Dev. 21, 384-393 (2012).
21. Nair, R. et al. Redefining the expression and function of the inhibitor of differentiation 1 in mammary gland development. PLoS ONE 5, e11947 (2010).
22. Kim, N. S. et al. Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling. Mol. Cell. Biol. 31, 4775-4788 (2011).
23. Dong, J. et al. ID4 regulates mammary gland development by suppressing p38MAPK activity. Development 138, 5247-5256 (2011).
24. Kouros-Mehr, H. et al. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13, 141-152 (2008).
25. Prat, A. & Perou, C. M. Deconstructing the molecular portraits of breast cancer. Mol. Oncol. 5, 5-23 (2011).
26. TCGA. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
27. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869-10874 (2001).
28. Rakha, E. A., Reis-Filho, J. S. & Ellis, I. O. Basal-like breast cancer: a critical review. J. Clin. Oncol. 26, 2568-2581 (2008).
29. Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15, 907-913 (2009).
30. Molyneux, G. et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7, 403-417 (2010).
31. Yun, K., Mantani, A., Garel, S., Rubenstein, J. & Israel, M. A. Id4 regulates neural progenitor proliferation and differentiation in vivo. Development 131, 5441-5448 (2004).
32. Ibarra, I., Erlich, Y., Muthuswamy, S. K., Sachidanandam, R. & Hannon, G. J. A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev. 21, 3238-3243 (2007).
33. Deugnier, M. A. et al. Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. Dev. Biol. 293, 414-425 (2006).
34. Danielson, K. G., Oborn, C. J., Durban, E. M., Butel, J. S. & Medina, D. Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc. Natl Acad. Sci. USA 81, 3756-3760 (1984).
35. dos Santos, C. O. et al. Molecular hierarchy of mammary differentiation yields refined markers of mammary stem cells. Proc. Natl Acad. Sci. USA 110, 7123-7130 (2013).
36. Spike, B. T. et al. A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer. Cell Stem Cell 10, 183-197 (2012).
37. Shan, L., Yu, M., Qiu, C. & Snyderwine, E. G. Id4 regulates mammary epithelial cell growth and differentiation and is overexpressed in rat mammary gland carcinomas. Am. J. Pathol. 163, 2495-2502 (2003).
38. Geling, A., Steiner, H., Willem, M., Bally-Cuif, L. & Haass, C. A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep. 3, 688-694 (2002).
39. Kalyuga, M. et al. ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer. PLoS Biol. 10, e1001461 (2012).
40. Welcsh, P. L. et al. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc. Natl Acad. Sci. USA 99, 7560-7565 (2002).
41. Cancer Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
42. Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123, 725-731 (2010).
43. Kendrick, H. et al. Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 9, 591 (2008).
44. Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750-2767 (2011).
45. Prat, A. et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12, R68 (2010).
46. Neve, R. M. et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515-527 (2006).
47. Plaks, V. et al. Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis. Cell Rep. 3, 70-78 (2013).
48. Soullier, S. et al. Diversification pattern of the HMG and SOX family members during evolution. J. Mol. Evol. 48, 517-527 (1999).
49. Chakrabarti, R. et al. Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. Stem Cells 30, 1496-1508 (2012).
50. Ventura, J. J. et al. p38[alpha] MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 39, 750-758 (2007).
51. Wen, H.-C. et al. p38a Signaling induces anoikis and lumen formation during mammary morphogenesis. Sci. Signal. 4, ra34 (2011).
52. de Candia, P., Akram, M., Benezra, R. & Brogi, E. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. Hum. Pathol. 37, 1032-1041 (2006).
53. Roldan, G., Delgado, L. & Muse, I. M. Tumoral expression of BRCA1, estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer. Cancer Biol. Ther. 5, 505-510 (2006).
54. Turner, N. C. et al. BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26, 2126-2132 (2007).
55. Wen, Y. H. et al. Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation. Breast Cancer Res. Treat. 135, 93-102 (2012).
56. Noetzel, E. et al. Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer. BMC Cancer 8, 154 (2008).
57. Umetani, N. et al. Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Oncogene 24, 4721-4727 (2005).
58. Youssef, K. K. et al. Adult interfollicular tumour-initiating cells are reprogrammed into an embryonic hair follicle progenitor-like fate during basal cell carcinoma initiation. Nat. Cell Biol. 14, 1282-1294 (2012).
59. Garraway, L. A. & Sellers, W. R. Lineage dependency and lineage-survival oncogenes in human cancer. Nat. Rev. Cancer 6, 593-602 (2006).
60. Liu, X. et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc. Natl Acad. Sci. USA 104, 12111-12116 (2007).
61. Hu, Y. & Smyth, G. K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70-78 (2009).
62. Wettenhall, J. M. & Smyth, G. K. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 20, 3705-3706 (2004).
63. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
64. Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500-501 (2006).
65. van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009 (2002).
66. Hu, Z. et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7, 96 (2006).